tiprankstipranks
Advertisement
Advertisement
Galera Therapeutics Sells Assets to Biossil Inc.
PremiumCompany AnnouncementsGalera Therapeutics Sells Assets to Biossil Inc.
6M ago
Biossil to acquire Galera’s dismutase mimetics portfolio for up to $105M
Premium
The Fly
Biossil to acquire Galera’s dismutase mimetics portfolio for up to $105M
6M ago
Galera Therapeutics Sells Assets to Biossil Inc.
Premium
Company Announcements
Galera Therapeutics Sells Assets to Biossil Inc.
6M ago
UroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
PremiumThe FlyUroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
2y ago
Galera Therapeutics Announces Wind-Up and Special Stockholder Meeting
Premium
Company Announcements
Galera Therapeutics Announces Wind-Up and Special Stockholder Meeting
2y ago
Galera Therapeutics reports Q2 EPS (7c) vs. (48c) last year
Premium
The Fly
Galera Therapeutics reports Q2 EPS (7c) vs. (48c) last year
2y ago
Galera Therapeutics Restructures Leadership and Cuts Costs
PremiumCompany AnnouncementsGalera Therapeutics Restructures Leadership and Cuts Costs
2y ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2y ago
Galera Therapeutics reports Q1 EPS (8c) vs (50c) last year
Premium
The Fly
Galera Therapeutics reports Q1 EPS (8c) vs (50c) last year
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100